ARCHIVES

In Brief: NCAB To Hear Report On Controversial Special Virus Cancer Program March 19; Centers, Bladder Project Also On Agenda

This article is from The Cancer Letter archive.

Vol. 01 No. 05 | March 8, 1974

Download PDF Visit The Full Archive

Related Articles

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

In Brief: Weldon Gage named CFO at MD Anderson Cancer Center

December 12, 2014

News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages

March 2, 2012

Colorectal Screening Rates Lower In Safety Net System

September 25, 2009

Funding Opportunity.

July 12, 2002

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009